HUE035057T2 - Botulinum toxint és színezéket tartalmazó helyi hatású készítmény - Google Patents
Botulinum toxint és színezéket tartalmazó helyi hatású készítmény Download PDFInfo
- Publication number
- HUE035057T2 HUE035057T2 HUE11855190A HUE11855190A HUE035057T2 HU E035057 T2 HUE035057 T2 HU E035057T2 HU E11855190 A HUE11855190 A HU E11855190A HU E11855190 A HUE11855190 A HU E11855190A HU E035057 T2 HUE035057 T2 HU E035057T2
- Authority
- HU
- Hungary
- Prior art keywords
- toxin
- composition
- dye
- botulinum toxin
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
Claims (3)
- 8GTUUNÜM ΤΟΧίΝΪ έ$ színezéket tartalmazó helyi hatású készítmény SZASAOALMi IGÉNYPONTOK1, Helyi hatású vagy transzéra'nmiis készítmény, amely egy botuünufn loxim es egy szinezsAol tartalmaz.
- 2. Az 1 igénypont szenntl készítmény, ahol az a.mliksit készítmény tartalmaz egy hordozót, aboi az említett horpozo tartalmaz agy pozitívan féltőit poiípepüé gehriooC srninez agy vagy iófeb batékortysági egoport kapcsolódik az alábbiak köztá választva:-glyN-RGRGDRRQRRR4gíy^; fgiyís-VQRKKRRQRRR-f gly^ As (giyj^RKKRRQRRRsgiy^: ahol a p ás g alsó index leíemése egymástól feggetlénoi a 0-20-ig iaqaaö égés?, számok kozol választott & A 2 igénypont szánni· készítmény. ahol a hordozó az RKKRRORRR-0-{K}í5-G-RKKRRQRRR aminosav-szakvenciát iártalmazzá, A. Az 1 igénypont szennti készítmény. ahol a boiulinum toxin az alábbi csoportból válnsztnü: A. 3, Cl, D F. F és G szemtlpusá botaiinsm loxinok. §. A 4: igénypont szerinti késziirnány; ahol s béibíínum toxin tlsztitott bóíoiínam toxin moíékhía. is, A 1, Igénypont szerinti késziirnány. ahol a színezék egy látható színezék. A A i5, Igénypont szerinti késziirnány, ahoi a látható színezék agy méstetségóg színezék.
- 9. A δ igénypont szenntl kéezilmeny ahoi a színezék a következe csoportba, választott FOAC Bins He 1 FObG Blue No 2. FC&C Green Ho. S, FOSCReP Nő. 4ö: KO&C Red No. 3, RSÁG Yellow Hó. 5 és FD&C Rop No. 8. 9, A 8 igém/pcm szenntl készítmény, ahol a laihaio színezék természetes éteiszlnezsk 115. A 8 igénypont szénné készítmény. ahol a tsrmeszstes eteiszmezék az alábbi csoportból választóit loxanmll színezék, aswttö, kosáéit, beianín, kurkuma, sáfrány, paprika, pandan és pillangó borsé virág, TI. At. igénypont szébhti készítmény, ahol a szinszák egy linoreszcens színezék, 12, ·> ' álv'< t x mii |> xes' tmm'r " '"'CZ-r ez -O.XO. < x u e-« ·> mdamm B aktiéin narancs zöld tiuoiőszoens ieboríe, korkamm es cmk-ezamp.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161430868P | 2011-01-07 | 2011-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE035057T2 true HUE035057T2 (hu) | 2018-05-02 |
Family
ID=46457668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE11855190A HUE035057T2 (hu) | 2011-01-07 | 2011-12-22 | Botulinum toxint és színezéket tartalmazó helyi hatású készítmény |
Country Status (17)
Country | Link |
---|---|
US (3) | US20140154237A1 (hu) |
EP (2) | EP3248614A1 (hu) |
JP (4) | JP6444032B2 (hu) |
BR (1) | BR112013017311A2 (hu) |
CY (1) | CY1119427T1 (hu) |
DK (1) | DK2661276T3 (hu) |
ES (1) | ES2641068T3 (hu) |
HK (1) | HK1247553A1 (hu) |
HR (1) | HRP20171483T1 (hu) |
HU (1) | HUE035057T2 (hu) |
LT (1) | LT2661276T (hu) |
NO (1) | NO2661276T3 (hu) |
PL (1) | PL2661276T3 (hu) |
PT (1) | PT2661276T (hu) |
RS (1) | RS56460B1 (hu) |
SI (1) | SI2661276T1 (hu) |
WO (1) | WO2012094163A1 (hu) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007136616A (ru) * | 2005-03-03 | 2009-04-10 | Риванс Терапьютикс, Инк. (Us) | Композиция и способ для местного применения и чрескожного введения ботулинового токсина |
SG10202100698QA (en) | 2008-12-31 | 2021-02-25 | Revance Therapeutics Inc | Injectable Botulinum Toxin Formulations |
CN102869373B (zh) * | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
EP3103472A1 (en) * | 2012-03-22 | 2016-12-14 | ReVance Therapeutics, Inc. | Method of treatment of wrinkles using topical chemodenervating agents |
KR20180077202A (ko) * | 2015-10-29 | 2018-07-06 | 레반스 테라퓨틱스, 아이엔씨. | 주사용 보툴리눔 독소 제제 및 긴 지속기간의 치료적 또는 미용적 효과를 갖는 이를 이용한 방법 |
CA3035473A1 (en) | 2016-09-13 | 2018-03-22 | Allergan, Inc. | Non-protein clostridial toxin compositions |
JP2020520917A (ja) * | 2017-05-18 | 2020-07-16 | ルバンス セラピュティックス インク.Revance Therapeutics,Inc. | 頸部ジストニアの治療方法 |
WO2019046311A1 (en) | 2017-08-28 | 2019-03-07 | Revance Therapeutics, Inc. | TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS |
US20210321696A1 (en) * | 2020-04-20 | 2021-10-21 | First Step Holdings, Llc | Covid mask |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4286016A (en) * | 1979-04-12 | 1981-08-25 | The Drackett Company | Pouch bleach |
US4797128A (en) * | 1984-12-10 | 1989-01-10 | Quadrex Hps, Inc. | Method of and apparatus for cleaning garments and soft goods contaminated with nuclear, chemical and/or biological contaminants |
US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
US5624636A (en) * | 1994-11-07 | 1997-04-29 | Univ. Of Texas Board Of Regents | Hypochlorite based disinfectant for dental impressions |
US6444209B1 (en) | 1996-10-28 | 2002-09-03 | Wisconsin Alumni Research Foundation | Hybrid botulinal neurotoxins |
US6566574B1 (en) | 1998-06-30 | 2003-05-20 | Sandia Corporation | Formulations for neutralization of chemical and biological toxants |
US6417423B1 (en) * | 1998-09-15 | 2002-07-09 | Nanoscale Materials, Inc. | Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
GB2386246B (en) | 2001-11-01 | 2005-06-29 | Marconi Applied Techn Ltd | Electron beam tube apparatus |
US6706092B2 (en) | 2002-04-17 | 2004-03-16 | Alliedsignal Inc. | Chemical/Biological decontamination filter |
US7582595B1 (en) | 2002-11-06 | 2009-09-01 | Taylor Lawnie H | Hypochlorous acid/alkali metal hydoxide-containing products, methods and equipment for removing stains from fabrics |
US8048423B2 (en) * | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
US7776292B2 (en) * | 2004-01-16 | 2010-08-17 | Cdic, Inc. | Method and apparatus for bioweapon decontamination |
ES2691498T3 (es) | 2004-03-03 | 2018-11-27 | Revance Therapeutics, Inc. | Aplicación tópica y liberación transdérmica de toxinas botulínicas |
ATE516498T1 (de) * | 2004-05-20 | 2011-07-15 | Wako Pure Chem Ind Ltd | Verfahren zum testen von hyaluronsäure mit hyaluronsäure-bindungsprotein |
US20080220021A1 (en) | 2005-02-14 | 2008-09-11 | Pankaj Modi | Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
RU2007136616A (ru) * | 2005-03-03 | 2009-04-10 | Риванс Терапьютикс, Инк. (Us) | Композиция и способ для местного применения и чрескожного введения ботулинового токсина |
US20070154493A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing botulinum toxin type a treatment |
NZ572207A (en) * | 2006-03-24 | 2012-02-24 | Auxilium Int Holdings Inc | Stabilized compositions containing alkaline labile drugs |
JP2009534309A (ja) * | 2006-03-31 | 2009-09-24 | マサチューセッツ インスティテュート オブ テクノロジー | 治療剤の標的化送達のためのシステム |
DE102006019447A1 (de) * | 2006-04-24 | 2007-10-25 | Dressler, Dirk, Dr. | Markierung von Botulinum Toxin |
JP2010519211A (ja) * | 2007-02-15 | 2010-06-03 | アラーガン、インコーポレイテッド | 膀胱もしくは前立腺障害または多汗症を処置するためのボツリヌス毒素および酵素の使用 |
US7993601B2 (en) * | 2007-03-06 | 2011-08-09 | Steris Inc. | Decontamination unit and process |
JP2009001423A (ja) * | 2007-05-21 | 2009-01-08 | Life:Kk | 感染性廃棄物用回収袋又は容器および感染性廃棄物処理方法 |
US8445650B2 (en) * | 2007-09-25 | 2013-05-21 | Thomas Jefferson University | Mutant botulinum neurotoxin serotype A polypeptide and uses thereof |
US20090148342A1 (en) * | 2007-10-29 | 2009-06-11 | Bromberg Steven E | Hypochlorite Technology |
US20090250626A1 (en) | 2008-04-04 | 2009-10-08 | Hexatech, Inc. | Liquid sanitization device |
SG10202100698QA (en) * | 2008-12-31 | 2021-02-25 | Revance Therapeutics Inc | Injectable Botulinum Toxin Formulations |
CN102869373B (zh) | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
-
2011
- 2011-12-22 NO NO11855190A patent/NO2661276T3/no unknown
- 2011-12-22 DK DK11855190.2T patent/DK2661276T3/en active
- 2011-12-22 LT LTEP11855190.2T patent/LT2661276T/lt unknown
- 2011-12-22 US US13/978,673 patent/US20140154237A1/en not_active Abandoned
- 2011-12-22 JP JP2013548424A patent/JP6444032B2/ja not_active Expired - Fee Related
- 2011-12-22 EP EP17178151.1A patent/EP3248614A1/en active Pending
- 2011-12-22 SI SI201131290T patent/SI2661276T1/sl unknown
- 2011-12-22 RS RS20171000A patent/RS56460B1/sr unknown
- 2011-12-22 HU HUE11855190A patent/HUE035057T2/hu unknown
- 2011-12-22 EP EP11855190.2A patent/EP2661276B1/en not_active Revoked
- 2011-12-22 PL PL11855190T patent/PL2661276T3/pl unknown
- 2011-12-22 BR BR112013017311A patent/BR112013017311A2/pt not_active Application Discontinuation
- 2011-12-22 PT PT118551902T patent/PT2661276T/pt unknown
- 2011-12-22 US US13/334,283 patent/US20120294844A1/en not_active Abandoned
- 2011-12-22 ES ES11855190.2T patent/ES2641068T3/es active Active
- 2011-12-22 WO PCT/US2011/066728 patent/WO2012094163A1/en active Application Filing
-
2016
- 2016-09-09 JP JP2016177053A patent/JP6605420B2/ja not_active Expired - Fee Related
-
2017
- 2017-09-13 CY CY20171100970T patent/CY1119427T1/el unknown
- 2017-10-04 HR HRP20171483TT patent/HRP20171483T1/hr unknown
-
2018
- 2018-05-25 HK HK18106889.1A patent/HK1247553A1/zh unknown
- 2018-07-05 JP JP2018128169A patent/JP2018188447A/ja active Pending
-
2020
- 2020-07-02 JP JP2020114910A patent/JP2020172519A/ja active Pending
- 2020-12-07 US US17/114,486 patent/US20210189326A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20140154237A1 (en) | 2014-06-05 |
BR112013017311A2 (pt) | 2016-10-04 |
JP6605420B2 (ja) | 2019-11-13 |
US20120294844A1 (en) | 2012-11-22 |
JP2018188447A (ja) | 2018-11-29 |
RS56460B1 (sr) | 2018-01-31 |
SI2661276T1 (sl) | 2017-12-29 |
JP2017025083A (ja) | 2017-02-02 |
EP2661276A1 (en) | 2013-11-13 |
PT2661276T (pt) | 2017-10-06 |
PL2661276T3 (pl) | 2018-03-30 |
JP2020172519A (ja) | 2020-10-22 |
JP6444032B2 (ja) | 2018-12-26 |
LT2661276T (lt) | 2017-12-11 |
CY1119427T1 (el) | 2018-03-07 |
HRP20171483T1 (hr) | 2017-12-01 |
WO2012094163A1 (en) | 2012-07-12 |
NO2661276T3 (hu) | 2017-12-30 |
HK1247553A1 (zh) | 2018-09-28 |
EP2661276B1 (en) | 2017-08-02 |
US20210189326A1 (en) | 2021-06-24 |
JP2014502969A (ja) | 2014-02-06 |
EP2661276A4 (en) | 2014-09-03 |
ES2641068T3 (es) | 2017-11-07 |
EP3248614A1 (en) | 2017-11-29 |
DK2661276T3 (en) | 2017-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2661276T3 (en) | TOPICAL COMPOSITION INCLUDING BOTULINUM TOXIN AND A COLOR | |
US10744078B2 (en) | Compositions and methods for topical application and transdermal delivery of botulinum toxins | |
EP1856139B1 (en) | Compositions and methods for topical application and transdermal delivery of an oligopeptide | |
EP2656859B1 (en) | Topical application and transdermal delivery of botulinum toxins | |
KR102363878B1 (ko) | 주사용 보툴리눔 독소 제제 | |
JP6589218B2 (ja) | アンチプロオキシダント・グリセリルオクチルアスコルビン酸誘導体その製法及び用途 | |
US20070190004A1 (en) | Substances with a probiotic action used in deodorants | |
JP6803732B2 (ja) | γ−オリザノール含有化粧料 | |
JPWO2020004649A1 (ja) | 被膜形成組成物 | |
WO2022092284A1 (ja) | 脂質ペプチドとショ糖エステルを含む組成物 | |
CN116744892A (zh) | 包含脂质肽和蔗糖酯的组合物 |